Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03839212 · ClinicalTrials.gov registry record · NA
The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men
A NA study of Human Immunodeficiency Virus and Cardiometabolic Risk, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT03839212: Completed NA study of Human Immunodeficiency Virus and Cardiometabolic Risk, sponsored by University of Miami.
NCT03839212 is a NA study of Human Immunodeficiency Virus and Cardiometabolic Risk that has completed, run by University of Miami. The registered enrollment target is 18 participants, below the 183-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03839212, a NA study of Human Immunodeficiency Virus and Cardiometabolic Risk, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven months. Participants will be interviewed and asked to take part in walking groups.
Primary Outcome
Number of eligible participants refusing to participate.
Conditions Studied
Interventions
- BEHAVIORAL HOLA Component 1
- BEHAVIORAL HOLA Component 2
- BEHAVIORAL HOLA Component 3
- BEHAVIORAL HOLA Component 4
Study Locations (1)
Florida
- Jackson Memorial Mental Health Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2020-10-27 |
| Phase | NA |
What the finished NCT03839212 record still lists
NCT03839212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 183-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 4 interventions - of which HOLA Component 1 is the first listed.
NCT03839212 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03839212 about?
NCT03839212 is a clinical study titled "The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men". The purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven months. Participant...
What is the current status of trial NCT03839212?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-10-01. Estimated completion is 2020-10-27.
What conditions does trial NCT03839212 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus, Cardiometabolic Risk.
What interventions are being tested in trial NCT03839212?
The interventions under investigation include: HOLA Component 1 (BEHAVIORAL), HOLA Component 2 (BEHAVIORAL), HOLA Component 3 (BEHAVIORAL), HOLA Component 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03839212?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03839212 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03839212's enrollment target sits among peer trials
18 33rd of 39 higher than 5 of 39 other Human Immunodeficiency Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Immunodeficiency Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
ACTIVE NOT RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI